B Pure Pressed Powder for Acne Prone Skin Tan

Description

This product is identified by the code 51945-4 and is associated with the package labeling effective from June 12, 2024. The outer packaging is represented visually in the referenced image file "Outer Package0.jpg." The labeling is designed to provide essential information regarding the product's use and handling.

Uses and Indications

This drug is indicated for the treatment of acne.

There are no teratogenic effects associated with this medication. Additionally, no nonteratogenic effects have been reported.

Dosage and Administration

The product should be applied evenly over the entire face using a makeup brush, ensuring to avoid the eye area. The application should begin at the center of the face and progress outward toward the periphery. This technique promotes uniform coverage and optimal results.

Contraindications

This product is contraindicated for use around the eye area due to the potential for irritation and adverse effects. Additionally, if irritation occurs during use, discontinue application immediately.

Warnings and Precautions

For external use only. Healthcare professionals should advise patients to avoid application in the eye area, as this product is not intended for use around the eyes.

When used in conjunction with other topical acne medications, there is a potential for increased dryness and skin irritation. It is essential to monitor patients for signs of irritation, and if such symptoms occur, discontinuation of the product should be recommended. Regular assessment of the skin condition may be necessary to ensure safe and effective use.

Side Effects

Patients using this product should be aware that it is intended for external use only. The application of this topical acne medication may lead to dryness and skin irritation, particularly if used concurrently with other topical acne treatments. In the event of irritation, it is advised to discontinue use immediately. Additionally, caution should be exercised to avoid application around the eye area, as this may exacerbate irritation or lead to other adverse effects.

Drug Interactions

The concomitant use of other topical acne medications may lead to increased dryness and skin irritation. It is advisable to monitor the skin condition closely when these agents are used together. If excessive dryness or irritation occurs, dosage adjustments or a reduction in the frequency of application may be necessary to mitigate these effects.

Packaging & NDC

Below are the non-prescription pack sizes of B Pure Pressed Powder for Acne Prone Skin Tan (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. Safety and efficacy in pediatric populations have not been established, and caution is advised when considering its use in this demographic.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

There is no information available regarding the use of B PURE PRESSED POWDER FOR ACNE PRONE SKIN TAN during pregnancy. As such, the safety of this product in pregnant patients has not been established, and there are no known dosage modifications or special precautions recommended for use in this population. Healthcare professionals should exercise caution and consider the lack of data when advising women of childbearing potential regarding the use of this product during pregnancy.

Lactation

There is no specific information regarding the use of B Pure Pressed Powder for Acne Prone Skin, Tan in lactating mothers or its effects on breastfed infants. Healthcare professionals should consider the lack of data when advising lactating mothers on the use of this product.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to the use of this medication. Consequently, there is no information available regarding dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise, as the clinical presentation can vary depending on the substance involved. Common symptoms of overdose may include, but are not limited to, respiratory depression, altered mental status, cardiovascular instability, and gastrointestinal disturbances.

In the event of an overdose, immediate medical intervention is recommended. Healthcare providers should initiate supportive care, which may include maintaining airway patency, providing supplemental oxygen, and monitoring vital signs. The use of activated charcoal may be considered if the patient presents within a suitable timeframe and if the ingestion was recent.

Furthermore, it is crucial to consult local poison control centers or toxicology experts for guidance on specific management protocols and antidotes, if applicable. Continuous assessment and supportive measures should be prioritized until the patient stabilizes or further treatment is determined.

Documentation of the incident, including the substance involved, estimated dose, time of ingestion, and any symptoms observed, is vital for ongoing management and potential reporting requirements.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients that the use of this product in conjunction with other topical acne medications may lead to increased dryness and skin irritation. It is important for patients to monitor their skin condition closely and to discontinue use of the product if any irritation occurs. Additionally, healthcare providers should emphasize that this product should not be applied around the eye area to avoid potential adverse effects.

Storage and Handling

The product is supplied in various package configurations, with specific NDC numbers available for identification. It is essential to store the product at room temperature to maintain its efficacy and stability. No special handling requirements are noted; however, standard precautions should be observed to ensure the integrity of the product during storage.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for B Pure Pressed Powder for Acne Prone Skin Tan, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)